
The Massachusetts-based cell therapy company SQZ Biotech, has announced the expansion of its collaboration with Swiss pharma giant Roche, in …

A 20 year old man died after a single leukaemia cell accidentally ended up in a batch of cells that …

The Nobel Prize for physiology or medicine has been awarded to both Professor James P Allison and Tasuku Honjo for …

Swiss multinational Roche has acquired the privately held immuno-oncology company Tusk Therapeutics in a deal that could be worth up …

French pharma firm Ipsen has announced the appointment of Dr. Yan Moore as Senior Vice President, Head of Oncology Therapeutic …

Lack of access to CAR T therapies in the United Kingdom could hinder the development of effective personalised cancer treatments, …

Cancer treatment is making leaps and bounds, but public focus tends to gravitate towards the therapies themselves. Matt Fellows explores …

Shire has completed the sale of its oncology franchise to French firm Servier for $2.4 billion, handing over the global …

Researchers at Queen’s University Belfast have been trialling a new form of “radical radiotherapy” which can be delivered in just …

Novartis has revealed that it has jettisoned two of its clinical stage oncology products along with exclusive global development and …

Bristol-Myers Squibb’s flagship immunotherapy Opdivo (nivolumab) has broken ground to become the first and only PD-1 inhibitor to be made …

Just as it ramps up its cancer-fighting efforts, Eli Lilly has revealed that its Senior Vice President and President of …

Swiftly following up its $1.6 billion splash to pick up Armo BioSciences last week, Eli Lilly has agreed to acquire …

The Spring 2018 edition of Pharmafile, our long-running bi-annual guide to the latest trends, projections and thought leadership positions in …

Shire has announced that it has entered a definitive agreement for French drugmaker Servier to take on its oncology business. …